Thought yesterday's ann was pretty disappointing. Seems like the direction of the company has been dictated by the new investor. Can see Thromboview getting sold off and the rest of the company moved to China. Reminds me of RBY.
- Forums
- ASX - By Stock
- CT1
- keep accumulating
keep accumulating, page-15
Featured News
Add CT1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.949M |
Open | High | Low | Value | Volume |
0.2¢ | 0.2¢ | 0.2¢ | $4.087K | 2.043M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
29 | 21195490 | 0.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.2¢ | 856410 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
29 | 21195490 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.002 | 856410 | 2 |
0.003 | 25062405 | 5 |
0.004 | 46394996 | 9 |
0.005 | 25000000 | 3 |
0.007 | 2500000 | 2 |
Last trade - 14.36pm 12/11/2024 (20 minute delay) ? |
Featured News
CT1 (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online